Jorge Arbelbide

433 total citations
30 papers, 252 citations indexed

About

Jorge Arbelbide is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Jorge Arbelbide has authored 30 papers receiving a total of 252 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 8 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in Jorge Arbelbide's work include Acute Myeloid Leukemia Research (15 papers), Multiple Myeloma Research and Treatments (6 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Jorge Arbelbide is often cited by papers focused on Acute Myeloid Leukemia Research (15 papers), Multiple Myeloma Research and Treatments (6 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Jorge Arbelbide collaborates with scholars based in Argentina, Spain and Chile. Jorge Arbelbide's co-authors include Dorotea Fantl, Irma Slavutsky, Tomás Meroño, Laura Boero, Patricia Sorroche, Fernando Brites, Carlos G. Musso, Claudia Corrado, Leonardo Gómez Rosso and Hernán Garcı́a Rivello and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Clinical Nutrition.

In The Last Decade

Jorge Arbelbide

29 papers receiving 249 citations

Peers

Jorge Arbelbide

HEMAT

GENET

ONCOL

PHYSI

Elahe Khodadi Iran

David Ledieu Switzerland

Katayoun Pourvali Iran

Anne E. Wyman United States

Takeshi Hagino Japan

Simona Roggero Italy

Claus Niederau Germany

Jennifer A. Tomczak United States

Terrence Tan Australia

Jun Xue China

Elahe Khodadi Iran

Jorge Arbelbide

129 ×1.0

HEMAT

123 ×1.3

71 ×1.2

GENET

63 ×1.8

ONCOL

16 ×0.5

PHYSI

Citations per year, relative to Jorge Arbelbide Jorge Arbelbide (= 1×) peers Elahe Khodadi

Countries citing papers authored by Jorge Arbelbide

Since Specialization

Citations

This map shows the geographic impact of Jorge Arbelbide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge Arbelbide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge Arbelbide more than expected).

Fields of papers citing papers by Jorge Arbelbide

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorge Arbelbide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge Arbelbide. The network helps show where Jorge Arbelbide may publish in the future.

Co-authorship network of co-authors of Jorge Arbelbide

This figure shows the co-authorship network connecting the top 25 collaborators of Jorge Arbelbide. A scholar is included among the top collaborators of Jorge Arbelbide based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorge Arbelbide. Jorge Arbelbide is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rivello, Hernán Garcı́a, et al.. (2024). Assessing the Relevance of Non-molecular Prognostic Systems for Myelodysplastic Syndrome in the Era of Next-Generation Sequencing. Annals of Laboratory Medicine. 45(1). 44–52. 2 indexed citations

Aguirre, M. A., et al.. (2024). Cardiac and autologous stem cell transplantation hematopoietic in patients with AL amyloidosis. 93(4). 1 indexed citations

Arbelbide, Jorge, et al.. (2023). Autologous stem cell transplantation in patients older than 65 years with multiple myeloma: a real-world study. Hematology Transfusion and Cell Therapy. 46. S13–S20. 1 indexed citations

Basquiera, Ana Lisa, et al.. (2022). Temporal trends in hematopoietic stem cell transplantation in Argentina between 2009 and 2018: A collaborative study by GATMO-TC and INCUCAI. Hematology Transfusion and Cell Therapy. 45(2). 224–234.

González, Jacqueline, Ana Lisa Basquiera, Dorotea Fantl, et al.. (2021). Prognostic assessment for chronic myelomonocytic leukemia in the context of the World Health Organization 2016 proposal: a multicenter study of 280 patients. Annals of Hematology. 100(6). 1439–1449. 4 indexed citations

Arbelbide, Jorge, et al.. (2020). Nonimmune-acquired factor XIII deficiency: a cause of high volume and delayed postoperative hemorrhage. Blood Coagulation & Fibrinolysis. 31(8). 511–516. 7 indexed citations

Rivas, María Marta, Jorge Arbelbide, Ana Lisa Basquiera, et al.. (2019). Allogeneic stem cell transplantation improves survival in relapsed Hodgkin lymphoma patients achieving complete remission after salvage treatment. Bone Marrow Transplantation. 55(1). 117–125. 9 indexed citations

Giunta, Diego, et al.. (2019). Incidence of Myelodysplastic Syndromes from a Medical Care Program in Buenos Aires, Argentina. Clinical Lymphoma Myeloma & Leukemia. 19. S346–S346. 2 indexed citations

Arbelbide, Jorge, et al.. (2017). Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity. International Urology and Nephrology. 49(12). 2171–2175. 24 indexed citations

10.

Enrico, Alicia, et al.. (2017). Influence of Acute Myeloid Leukemia Progression on the Prognosis of 831 Patients With Myelodysplastic Syndromes From the Argentine Database. Clinical Lymphoma Myeloma & Leukemia. 17(11). 743–752.e5. 2 indexed citations

11.

González, Jacqueline, et al.. (2017). Influence of TNF and IL6 gene polymorphisms on the severity of cytopenias in Argentine patients with myelodysplastic syndromes. Annals of Hematology. 96(8). 1287–1295. 5 indexed citations

12.

Angriman, Federico, et al.. (2015). Promyelocytic Blastic Crisis in Chronic Myeloid Leukemia During Imatinib Treatment. SHILAP Revista de lepidopterología. 32(2). 193–194. 2 indexed citations

13.

Fantl, Dorotea, et al.. (2014). Non-Shelterin Telomere Genes Deregulation in Plasma Cell Disorders. Blood. 124(21). 2020–2020. 1 indexed citations

14.

Arbelbide, Jorge, et al.. (2013). Expression profile of shelterin components in plasma cell disorders. Clinical significance of POT1 overexpression. Blood Cells Molecules and Diseases. 52(2-3). 134–139. 20 indexed citations

15.

Scibona, Paula, et al.. (2012). Prevalence of CYP2C9 and VKORC1 alleles in the Argentine population and implications for prescribing dosages of anticoagulants. Genetics and Molecular Research. 11(1). 70–76. 17 indexed citations

16.

Arbelbide, Jorge, et al.. (2011). New Recurrent Chromosome Alterations in Patients with Multiple Myeloma and Plasma Cell Leukemia. Cytogenetic and Genome Research. 134(4). 249–259. 2 indexed citations

17.

Meroño, Tomás, Leonardo Gómez Rosso, Patricia Sorroche, et al.. (2010). High risk of cardiovascular disease in iron overload patients. European Journal of Clinical Investigation. 41(5). 479–486. 31 indexed citations

18.

Arbelbide, Jorge, et al.. (2010). Altered mRNA Expression of Telomere-Associated Genes in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma. Molecular Medicine. 16(11-12). 471–478. 16 indexed citations

19.

Arbelbide, Jorge, et al.. (2009). DNA methylation analysis of tumor suppressor genes in monoclonal gammopathy of undetermined significance. Annals of Hematology. 89(2). 191–199. 34 indexed citations

20.

Meroño, Tomás, Patricia Sorroche, Leonardo Gómez Rosso, et al.. (2009). Proatherogenic disturbances in lipoprotein profile, associated enzymes and transfer proteins in women with iron deficiency anaemia. Clinical Biochemistry. 43(4-5). 416–423. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact